Cynosure Group LLC Has $389,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Cynosure Group LLC reduced its stake in HCA Healthcare by 61.2%, now holding 1,127 shares valued at approximately $389,000.
• HCA Healthcare recently announced a quarterly dividend of $0.72 per share, with a yield of 0.8% and a payout ratio of 12.11%.
• Despite mixed analyst ratings, HCA Healthcare has a consensus average rating of "Moderate Buy" and a price target of $395.69, with recent earnings exceeding expectations at $6.84 per share.

Cynosure Group LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 61.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,127 shares of the company's stock after selling 1,781 shares during the period. Cynosure Group LLC's holdings in HCA Healthcare were worth $389,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $1,021,000. Glass Jacobson Investment Advisors llc purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $143,000. Distillate Capital Partners LLC purchased a new position in HCA Healthcare in the 4th quarter valued at about $24,160,000. Legacy Investment Solutions LLC increased its stake in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares during the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $2,656,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the subject of several research analyst reports. Morgan Stanley reduced their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Barclays dropped their target price on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research report on Monday, July 28th. JPMorgan Chase & Co. increased their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Wells Fargo & Company dropped their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research report on Thursday. Finally, Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Nine investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $401.62.

HCA Healthcare Stock Performance

HCA traded up $2.48 on Thursday, hitting $392.94. The company had a trading volume of 457,366 shares, compared to its average volume of 1,576,535. The company's fifty day moving average price is $370.06 and its 200 day moving average price is $350.57. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The stock has a market cap of $91.94 billion, a price-to-earnings ratio of 16.52, a price-to-earnings-growth ratio of 1.23 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company earned $5.50 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's payout ratio is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.